1. Home
  2. RGEN vs DCI Comparison

RGEN vs DCI Comparison

Compare RGEN & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DCI
  • Stock Information
  • Founded
  • RGEN 1981
  • DCI 1915
  • Country
  • RGEN United States
  • DCI United States
  • Employees
  • RGEN N/A
  • DCI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DCI Pollution Control Equipment
  • Sector
  • RGEN Health Care
  • DCI Industrials
  • Exchange
  • RGEN Nasdaq
  • DCI Nasdaq
  • Market Cap
  • RGEN 8.0B
  • DCI 7.9B
  • IPO Year
  • RGEN N/A
  • DCI 1987
  • Fundamental
  • Price
  • RGEN $118.15
  • DCI $68.19
  • Analyst Decision
  • RGEN Buy
  • DCI Hold
  • Analyst Count
  • RGEN 12
  • DCI 4
  • Target Price
  • RGEN $172.67
  • DCI $71.33
  • AVG Volume (30 Days)
  • RGEN 819.3K
  • DCI 430.0K
  • Earning Date
  • RGEN 04-29-2025
  • DCI 06-03-2025
  • Dividend Yield
  • RGEN N/A
  • DCI 1.58%
  • EPS Growth
  • RGEN N/A
  • DCI 11.79
  • EPS
  • RGEN N/A
  • DCI 3.42
  • Revenue
  • RGEN $650,429,000.00
  • DCI $3,633,400,000.00
  • Revenue This Year
  • RGEN $13.93
  • DCI $2.95
  • Revenue Next Year
  • RGEN $14.35
  • DCI $3.44
  • P/E Ratio
  • RGEN N/A
  • DCI $19.94
  • Revenue Growth
  • RGEN 4.88
  • DCI 4.46
  • 52 Week Low
  • RGEN $102.97
  • DCI $57.45
  • 52 Week High
  • RGEN $182.52
  • DCI $78.95
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 38.20
  • DCI 51.94
  • Support Level
  • RGEN $120.11
  • DCI $69.81
  • Resistance Level
  • RGEN $129.42
  • DCI $71.36
  • Average True Range (ATR)
  • RGEN 6.02
  • DCI 0.96
  • MACD
  • RGEN -1.20
  • DCI -0.05
  • Stochastic Oscillator
  • RGEN 5.96
  • DCI 43.79

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

Share on Social Networks: